Holen Sie sich die Stockscreener-App
0.5499
6.04%
0.0313
Handel nachbörslich:
.55
0.000100
+0.02%
Schlusskurs vom Vortag:
$0.5186
Offen:
$0.52
24-Stunden-Volumen:
993.21K
Relative Volume:
1.63
Marktkapitalisierung:
$20.54M
Einnahmen:
$53.55M
Nettoeinkommen (Verlust:
$-15.13M
KGV:
-0.5092
EPS:
-1.08
Netto-Cashflow:
$-23.86M
1W Leistung:
+6.78%
1M Leistung:
+22.17%
6M Leistung:
+17.00%
1J Leistung:
-13.58%
1-Tages-Spanne:
$0.5111
$0.57
1-Wochen-Bereich:
$0.4967
$0.57
52-Wochen-Spanne:
$0.2801
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Firmenname
Cosmos Health Inc
Sektor
Branche
Telefon
312-536-3102
Adresse
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Vergleichen Sie COSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.5499 | 19.37M | 53.55M | -15.13M | -23.86M | -1.08 |
|
MCK
Mckesson Corporation
|
816.06 | 100.55B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
335.69 | 65.13B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
201.11 | 48.11B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
77.64 | 9.30B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.38 | 730.44M | 2.22M | -5.63M | -1.68M | -0.24 |
Cosmos Health Inc Aktie (COSM) Neueste Nachrichten
Insider Stock Purchases: January 09, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $81,000 in shares By Investing.com - Investing.com Canada
Why Cosmos Health Inc. stock could see breakout soonPortfolio Profit Report & Consistent Profit Alerts - ulpravda.ru
Why Cosmos Health Inc. (V67A) stock could be next leaderDividend Hike & Verified Technical Signals - ulpravda.ru
How Cosmos Health Inc. stock reacts to Fed rate cutsEarnings Overview Report & Daily Price Action Insights - ulpravda.ru
How currency fluctuations impact Cosmos Health Inc. stockJuly 2025 Snapshot & Fast Moving Trade Plans - ulpravda.ru
Layoff Watch: What catalysts could drive Cosmos Health Inc stock higherWeekly Volume Report & Free Technical Pattern Based Buy Signals - moha.gov.vn
Why Cosmos Health Inc. (V67A) stock trades below fair valueMarket Weekly Review & Technical Buy Zone Confirmation - ulpravda.ru
Why Cosmos Health Inc. stock could benefit from AI revolutionJobs Report & Expert Approved Momentum Ideas - ulpravda.ru
Cosmos Health CEO Siokas buys $65,000 in COSM stock By Investing.com - Investing.com Canada
How Cosmos Health Inc. stock benefits from strong dollarJuly 2025 Closing Moves & Short-Term High Return Ideas - ulpravda.ru
Analysis Recap: How Cosmos Health Inc. stock reacts to Fed rate cuts2025 Institutional Moves & AI Driven Stock Movement Reports - ulpravda.ru
Is Cosmos Health Inc. stock a safe haven assetMomentum Trading Signals & High Return Trading Strategies - ulpravda.ru
Insider Stock Purchases: January 07, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $72k in shares By Investing.com - Investing.com UK
Cosmos Health CEO Siokas buys $72k in shares - Investing.com
Cosmos Health to manufacture PathMuscle drug for Greek distributor By Investing.com - Investing.com Nigeria
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
Cosmos Health’s Wild Ride: Can COSM Survive Its Own Volatility? - AD HOC NEWS
Tangible book value per share of Cosmos Health Inc – MUN:V67A - TradingView — Track All Markets
Cosmos Health (COSM) Subsidiary to Manufacture PathMuscle for Li - GuruFocus
Cosmos Health stock rises on manufacturing deal with Libytec By Investing.com - Investing.com Australia
Cosmos Health stock rises on manufacturing deal with Libytec - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Enters Manufacturing Agreement for PathMuscle with Libytec Pharmaceutical in Greece - Quiver Quantitative
Cosmos Health to manufacture PathMuscle drug for Greek distributor - Investing.com
Cosmos Health Enters Manufacturing Agreement with Libytec - GlobeNewswire
New muscle spasm medicine expected to top 1.2M doses in Greece - Stock Titan
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units - Sahm
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy - ACCESS Newswire
How one healthcare supplier is remaking its business to dodge tariffs - Stock Titan
Cosmos Health receives Nasdaq non-compliance bid price notice - MSN
Siokas buys Cosmos Health (COSM) shares worth $43,000 By Investing.com - Investing.com Australia
Siokas buys Cosmos Health (COSM) shares worth $43,000 - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange - TradingView — Track All Markets
Will Cosmos Health Inc. (V67A) stock benefit from mergers2025 Macro Impact & Weekly Return Optimization Plans - Улправда
Can Cosmos Health Inc. (V67A) stock stage a strong rebound this quarterMarket Trend Review & AI Forecast Swing Trade Picks - Улправда
Can Cosmos Health Inc. stock resist sector downturnsJuly 2025 Recap & Daily Profit Focused Screening - Улправда
Is Cosmos Health Inc. (V67A) stock in buy zone after pullback2025 Market WrapUp & Weekly High Conviction Trade Ideas - Улправда
Cosmos Health is Forcing the Market to Reframe the Conversation - ACCESS Newswire
Will Cosmos Health Inc. stock deliver strong dividend growthWeekly Trade Recap & Verified Entry Point Detection - Улправда
Can Cosmos Health Inc. stock surprise with earnings upsideMarket Growth Report & High Accuracy Investment Signals - DonanımHaber
Aug Catalysts: How dovish Fed policy supports Cosmos Health Inc. (V67A) stock2025 Stock Rankings & Weekly High Potential Stock Alerts - Улправда
Aug Outlook: Will Cosmos Health Inc. stock return to pre crisis levelsJuly 2025 Big Picture & AI Optimized Trading Strategy Guides - Улправда
Is Cosmos Health Inc. stock a defensive play in 2025Trade Ideas & Low Volatility Stock Suggestions - Улправда
Analyst Downgrade: Will Cosmos Health Inc. (V67A) stock benefit from mergersMarket Sentiment Summary & Stock Timing and Entry Methods - Улправда
Can Cosmos Health Inc. (V67A) stock expand revenue streamsMarket Growth Report & Capital Protection Trade Alerts - Улправда
Finanzdaten der Cosmos Health Inc-Aktie (COSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.16%
8.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):